Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Crystalline polymorphs of Rivoceranib and Rivoceranib mesylate

US Patent 11434202 · Granted Sep 6, 2022

Assignee

Inventors

View full patent text on Google Patents →